Copyright © 2000 by the European Society of Cardiology.
A national survey of heart failure in French hospitals
revised June 15, 1999; accepted June 23, 1999
Abstract
Rationale The epidemiology of heart failure and patient management procedures may vary from one country to another. This study was designed to analyse the spectrum of patients hospitalized in France for heart failure.
Patients and Methods A registry involving 120 departments (cardiology, general medicine and geriatrics) and 1058 patients.
Results The patients' median age was 76 years, and the male/female ratio was 55/45. Echocardiography was performed in 77% of the cases: the left ventricular ejection fraction was <30% in 22%, between 30 and 40% in 25% and greater than 40% in 53%. Angiotensin-converting enzyme (ACE) inhibitors were prescribed to, respectively, 78% and 63% of patients with ejection fractions above and below 40%.
Conclusion In France, patients hospitalized for heart failure tend to be old and are often women; about one in two have relatively preserved left ventricular systolic function. ACE inhibitor prescription seems to be more frequent than currently reported. This survey confirms the clear gap between the populations in clinical trials and those in routine clinical practice.
Key Words: Heart failure, epidemiology, hospitalization, ejection fraction, age, ACE inhibitors
f1 Correspondence: Alain Cohen-Solal, Service de Cardiologie, Hopital Beaujon, 100 Boulevard du General Leclerc, 92110, Clichy, France.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. J. Remme, J. J.V. McMurray, F.D. R. Hobbs, A. Cohen-Solal, J. Lopez-Sendon, A. Boccanelli, F. Zannad, B. Rauch, K. Keukelaar, C. Macarie, et al. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians Eur. Heart J., July 2, 2008; 29(14): 1739 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Berry, M Brett, K Stevenson, J J V McMurray, and J Norrie Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure Heart, March 1, 2008; 94(3): 296 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Komajda, O. Hanon, M. Hochadel, F. Follath, K. Swedberg, A. Gitt, and J. G.F. Cleland Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I Eur. Heart J., June 1, 2007; 28(11): 1310 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Persson, E. Lonn, M. Edner, L. Baruch, C. C. Lang, J. J. Morton, J. Ostergren, R. S. McKelvie, and for the Investigators of the CHARM Echocardiograph Diastolic Dysfunction in Heart Failure With Preserved Systolic Function: Need for Objective Evidence: Results From the CHARM Echocardiographic Substudy-CHARMES J. Am. Coll. Cardiol., February 13, 2007; 49(6): 687 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N M Hawkins, D Wang, J J V McMurray, M A Pfeffer, K Swedberg, C B Granger, S Yusuf, S J Pocock, J Ostergren, E L Michelson, et al. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme Heart, January 1, 2007; 93(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Coste, P. Jourdain, and J. Pouchot A Gray Zone Assigned to Inconclusive Results of Quantitative Diagnostic Tests: Application to the Use of Brain Natriuretic Peptide for Diagnosis of Heart Failure in Acute Dyspneic Patients Clin. Chem., December 1, 2006; 52(12): 2229 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Passantino, R. Lagioia, F. Mastropasqua, and D. Scrutinio Short-Term Change in Distance Walked in 6 Min Is an Indicator of Outcome in Patients With Chronic Heart Failure in Clinical Practice J. Am. Coll. Cardiol., July 4, 2006; 48(1): 99 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Lenzen, E. Boersma, W. J.M. Scholte op Reimer, A. H.M.M. Balk, M. Komajda, K. Swedberg, F. Follath, M. Jimenez-Navarro, M. L. Simoons, and J. G.F. Cleland Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur. Heart J., December 2, 2005; 26(24): 2706 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Squire Managing patients with heart failure: the reality of clinical practice Eur. Heart J., December 2, 2005; 26(24): 2611 - 2613. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ahmed Association of Diastolic Dysfunction and Outcomes in Ambulatory Older Adults With Chronic Heart Failure J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2005; 60(10): 1339 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 GESICA Investigators Randomised trial of telephone intervention in chronic heart failure: DIAL trial BMJ, August 20, 2005; 331(7514): 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Berry, K Hogg, J Norrie, K Stevenson, M Brett, and J McMurray Heart failure with preserved left ventricular systolic function: a hospital cohort study Heart, July 1, 2005; 91(7): 907 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Zannad Acute heart failure syndromes: the 'Cinderella' of heart failure research Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B8 - B12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bendjelid, N. Schutz, P. M. Suter, G. Fournier, D. Jacques, S. Fareh, and J.-A Romand Does Continuous Positive Airway Pressure by Face Mask Improve Patients With Acute Cardiogenic Pulmonary Edema Due to Left Ventricular Diastolic Dysfunction? Chest, March 1, 2005; 127(3): 1053 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Roman-Sanchez, P. Conthe, J. Garcia-Alegria, J. Forteza-Rey, M. Montero, C. Montoto, and for the Heart Failure Working Group of the Spanish Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey QJM, February 1, 2005; 98(2): 127 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gustafsson, C. Torp-Pedersen, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure Eur. Heart J., October 1, 2004; 25(19): 1711 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.J Lenzen, W.J.M Scholte op Reimer, E Boersma, P.J.M.J Vantrimpont, F Follath, K Swedberg, J Cleland, and M Komajda Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur. Heart J., July 2, 2004; 25(14): 1214 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gustafsson, B. Brendorp, M. Seibaek, H. Burchardt, P. Hildebrandt, L. Kober, C. Torp-Pedersen, and DIAMOND Study Group Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure J. Am. Coll. Cardiol., March 3, 2004; 43(5): 771 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tendera The epidemiology of heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S2 - S6. [Abstract] [PDF]
|
|
|
|
|
|
K. Hogg, K. Swedberg, and J. McMurray Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis J. Am. Coll. Cardiol., February 4, 2004; 43(3): 317 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Johnson, Y. Jin, H. Quan, and B. Cujec Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1438 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gustafsson, C. Torp-Pedersen, B. Brendorp, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function Eur. Heart J., May 1, 2003; 24(9): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Study Group of Diagnosis of the Working Group, M. Komajda, F. Follath, K. Swedberg, J. Cleland, J.C. Aguilar, A. Cohen-Solal, R. Dietz, A. Gavazzi, W.H. Van Gilst, et al. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe: Part 2: treatment Eur. Heart J., March 1, 2003; 24(5): 464 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S D Hutcheon, N D Gillespie, I K Crombie, A D Struthers, and M E T McMurdo Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial Heart, October 1, 2002; 88(4): 373 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Heiat, C. P. Gross, and H. M. Krumholz Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials Arch Intern Med, August 12, 2002; 162(15): 1682 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Banerjee, T. Banerjee, A. Khand, A. L. Clark, and J. G. F. Cleland Diastolic heart failure: neglected or misdiagnosed? J. Am. Coll. Cardiol., January 2, 2002; 39(1): 138 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bellotti, L.P. Badano, N. Acquarone, R. Griffo, G. Lo Pinto, A.P. Maggioni, C. Mattiauda, G. Menardo, and P. Mombelloni Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study Eur. Heart J., April 1, 2001; 22(7): 596 - 604. [Abstract] [PDF]
|
|
|
|
|
|
A. M Tonkin GENERAL CARDIOLOGY: Evaluation of large scale clinical trials and their application to usual practice Heart, December 1, 2000; 84(6): 679 - 684. [Full Text]
|
|
|
|
|
|
J. McMurray Heart failure: we need more trials in typical patients Eur. Heart J., May 1, 2000; 21(9): 699 - 700. [PDF]
|
|